Dna Pharma LLP - pharma in Mumbai, Maharashtra, India. Directors, charges & compliance details.
LLPIN AAB-3851 Incorporated 11 March 2013 ROC Mumbai HQ Mumbai, Maharashtra, India
Struck Off Limited Liability Partnership pharma
Data last updated
Contribution obligation
₹1 Lakh
As per LLP agreement
LLP age
13 yrs
Est. 2013
Designated partners
2
As per MCA filings
Last financials
Mar 2024
Balance sheet date
LLP status
Struck Off
MCA master data
Registrar
Mumbai
ROC office
Incorporated
11 Mar 2013
Date of incorporation
Entity type
LLP
As registered with MCA

About Dna Pharma LLP

Data last updated:

Dna Pharma LLP was a limited liability partnership (LLP) based in Mumbai, Maharashtra, India. The LLP has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 11 March 2013.

The LLP was registered with the Registrar of Companies (ROC), Mumbai, under LLPIN AAB-3851.

The LLP had a total obligation of contribution of β‚Ή1 Lakh. It was led by designated partners Srinivas Hariharan and Shankar Srinivasan.

Its latest statement of accounts is for the year ended 31 March 2024. The registered office was at 12 Gunbow Street Fort, Mumbai, Maharashtra, India – 400001.

Company details

LLPIN AAB-3851
Incorporation Date 11 March 2013
Total Obligation of Contribution β‚Ή1 Lakh
ROC Mumbai
Listing Status Unlisted
Company Status Struck Off
Date of Last AGM 31 March 2024
Date of Balance Sheet 31 March 2024

Contact details

Dna Pharma LLP's registered office is in Mumbai, Maharashtra.

  • Registered Address
    12 Gunbow Street Fort, Mumbai, Maharashtra, India – 400001
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors
Comprehensive company report
Dna Pharma LLP - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout Β· GST invoice included

Financials of Dna Pharma LLP

FY 2024 filings available

Financial Statement Summary

Statement of Account and SolvencyFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income and Expenditure
Turnover
Other Income
Total Income
Purchases and Direct Costs
Personnel Expenses
Administrative Expenses
Interest
Depreciation
Total Expenses
Profit Before Tax
Tax
Profit After Tax
Profit Transferred to Partners
Assets and Liabilities
Partners' Contribution
Reserves and Surplus
Secured Loans
Unsecured Loans
Trade Payables
Other Liabilities and Provisions
Total Liabilities
Fixed Assets
Investments
Loans and Advances
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

Statement of Account and SolvencyFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
Net Profit Margin
Return on Partners' Funds
Return on Assets
Liquidity and Debt
Current Ratio
Debt to Partners' Funds
Interest Coverage
Efficiency and Growth
Asset Turnover
Receivable Days
Turnover Growth
Profit Growth

To see the full financial statements and ratios of Dna Pharma LLP, buy the company report.

Designated partners of Dna Pharma LLP

Dna Pharma has 2 current designated partners and 1 former designated partner. Current designated partners are listed first, with their designation and appointment date.

Designated Partners (as last reported)
NameDesignationAppointment DateTenureStatus
Srinivas HariharanDesignated Partner11 Mar 201313 Years 7 MonthsAs last reported
Shankar SrinivasanDesignated Partner30 Dec 20169 Years 9 MonthsAs last reported

MSME payment delays

No delayed payments to MSME suppliers are on our record for Dna Pharma LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Dna Pharma LLP; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Dna Pharma LLP has 3 designated partner changes on record since 2013: 2 appointments and 1 cessation. The latest: Shankar Srinivasan was appointed as Designated Partner on 30 Dec 2016.

AGM
Dna Pharma Llp last Annual general meeting of members was held on 31 Mar 2024 as per latest MCA records.
Filing
Dna Pharma Llp has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
Appointed
Shankar Srinivasan was appointed as Designated Partner.
Ceased
Raman Parameswaran Athipotta ceased to be Designated Partner.
Appointed
Srinivas Hariharan was appointed as Designated Partner.
Incorporation
11 Mar 2013
Dna Pharma Llp was registered on 11 Mar 2013 with Roc Mumbai & aged 13 years 7 months as per MCA records.

Frequently asked questions

Dna Pharma has a status of "Struck Off" as per MCA records. This means the LLP has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off LLP cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.

Dna Pharma was a limited liability partnership based in Mumbai, Maharashtra, India. The LLP worked in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 11 March 2013 and is registered under LLPIN AAB-3851. The LLP has been struck off by the Registrar of Companies and is no longer operational.

Dna Pharma had 2 designated partners:

The LLPIN (Limited Liability Partnership Identification Number) of Dna Pharma is AAB-3851. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.

The registered office of Dna Pharma is at 12 Gunbow Street Fort, Mumbai, Maharashtra, India – 400001.

Dna Pharma was incorporated on 11 March 2013. It is registered with the Registrar of Companies, Mumbai.

The latest financial statements of Dna Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 31 March 2024. Year-wise statements from 2015 are in the company report.

Dna Pharma operated in the pharma industry, in the pharmaceutical retailers and distributors segment. It worked in this industry before it was struck off.

Shankar Srinivasan was appointed as Designated Partner on 30 Dec 2016. Raman Parameswaran Athipotta ceased to be Designated Partner on 29 Dec 2016. Srinivas Hariharan was appointed as Designated Partner on 11 Mar 2013.

Dna Pharma can be reached at its registered office: 12 Gunbow Street Fort, Mumbai, Maharashtra, India – 400001.